Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|July 1, 1991
Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendationsK Fattinger, S Vozeh, A Olafsson, et al.Vnitrni Lekarstvi|April 2, 2003
[Characteristics of patients with osteopenia treated with glucocorticoids at the Osteoporosis Clinic of the Medical Faculty Hospital in Hradec Kralove]H Müllerová, M Prixová, J Vlcek, et al.Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|April 17, 2007
Deep vein thromboembolism in malignant diseasesM Zemková, R H B Meyboom, M Blazek, et al.Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|May 23, 2001
[Monitoring utilization of hypolipemic agents using an insurance company database]J Vlcek, K Macek, H Müllerová, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 22, 2008
Improvements in antibiotic prescribing by community paediatricians in the Czech RepublicV Jindrak, J Marek, V Vanis, et al.Journal of Thrombosis and Thrombolysis|January 20, 2019
Patterns in anticoagulant utilization in the Czech Republic during 2007-2017J Maly, S Dvorackova, E Zimcikova, et al.Clinical Immunology (Orlando, Fla.)|July 15, 2010
Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiencyT Freiberger, L Grodecká, B Ravcuková, et al.Clinical and Experimental Immunology|July 19, 2008
Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiencyJ Litzman, T Freiberger, B Grimbacher, et al.European Journal of Drug Metabolism and Pharmacokinetics|September 2, 1998
Distribution of fenofibric acid in lipoprotein fractions of patientsM Nobilis, J Kvetina, P Anzenbacher, et al.Vnitrni Lekarstvi|May 10, 2001
[Cross-sectional study of choice of drug therapy in the acute phase of treatment in acute myocardial infarct--part 1]J Vlcek, J Gregor, K Macek, et al.Pageof 5